Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
SPL-028 by Cybin for Generalized Anxiety Disorder (GAD): Likelihood of Approval
SPL-028 is under clinical development by Cybin and currently in Phase I for Generalized Anxiety Disorder (GAD). According to GlobalData,...